相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Roles and correlations of TIM-3 and LAG-3 with cytokines and chemokines in alcoholic liver disease
Ailyn Fadriquela et al.
CLINICA CHIMICA ACTA (2023)
Characteristics of immune checkpoint regulators and potential role of soluble TIM-3 and LAG-3 in male patients with alcohol-associated liver disease
Ailyn Fadriquela et al.
ALCOHOL (2022)
Immune-checkpoint inhibitors from cancer to COVID-19: A promising avenue for the treatment of patients with COVID-19 (Review)
Silvia Vivarelli et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2021)
Soluble TIM3 and Its Ligands Galectin-9 and CEACAM1 Are in Disequilibrium During Alcohol-Related Liver Disease and Promote Impairment of Anti-bacterial Immunity
Antonio Riva et al.
FRONTIERS IN PHYSIOLOGY (2021)
Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis
Wei Li et al.
HEPATOLOGY COMMUNICATIONS (2020)
The evolving landscape of 'next-generation' immune checkpoint inhibitors: A review
Luca Mazzarella et al.
EUROPEAN JOURNAL OF CANCER (2019)
Immune checkpoint receptors: homeostatic regulators of immunity
Antonio Riva et al.
HEPATOLOGY INTERNATIONAL (2018)
The TIM3-Gal9 immune checkpoint axis is inter-linked with severity of Alcoholic Liver Disease
A. Riva et al.
JOURNAL OF HEPATOLOGY (2018)
Dipeptidyl peptidase-4 inhibitor sitagliptin significantly reduced hepatitis C virus replication in a diabetic patient with chronic hepatitis C virus infection
Hidekatsu Yanai
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2014)
Truncated CXCL10 Is Associated With Failure to Achieve Spontaneous Clearance of Acute Hepatitis C Infection
Antonio Riva et al.
HEPATOLOGY (2014)